Kurt C. Gunter

1.9k total citations
22 papers, 1.2k citations indexed

About

Kurt C. Gunter is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Kurt C. Gunter has authored 22 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Molecular Biology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Kurt C. Gunter's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Pluripotent Stem Cells Research (3 papers) and Immune Cell Function and Interaction (3 papers). Kurt C. Gunter is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Pluripotent Stem Cells Research (3 papers) and Immune Cell Function and Interaction (3 papers). Kurt C. Gunter collaborates with scholars based in United States, United Kingdom and Italy. Kurt C. Gunter's co-authors include Ethan M. Shevach, Richard A. Kroczek, Thomas R. Malek, Ronald N. Germain, Arthur Weiss, Bruce Seligmann, Takashi Saito, R N Germain, Christina Chan and Wayne M. Yokoyama and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Kurt C. Gunter

20 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kurt C. Gunter United States 14 699 493 322 154 90 22 1.2k
Sazuku Nisitani Japan 17 730 1.0× 485 1.0× 156 0.5× 242 1.6× 91 1.0× 20 1.4k
Sten Braesch‐Andersen Sweden 15 763 1.1× 503 1.0× 175 0.5× 120 0.8× 50 0.6× 21 1.2k
JA Ledbetter United States 9 1.1k 1.5× 439 0.9× 484 1.5× 344 2.2× 83 0.9× 11 1.7k
Yuko Kozono Japan 14 820 1.2× 279 0.6× 151 0.5× 205 1.3× 73 0.8× 18 1.2k
Stephen E. Maher United States 22 844 1.2× 532 1.1× 152 0.5× 338 2.2× 66 0.7× 35 1.4k
Joseph Naemura United States 8 658 0.9× 318 0.6× 111 0.3× 180 1.2× 41 0.5× 9 1.2k
Nicole Boucheron Austria 17 1.0k 1.5× 477 1.0× 107 0.3× 291 1.9× 82 0.9× 29 1.4k
Sašo Čemerski United States 16 1.2k 1.8× 441 0.9× 162 0.5× 377 2.4× 92 1.0× 21 1.7k
Janko Nikolić‐Žugić United States 23 1.1k 1.6× 464 0.9× 166 0.5× 240 1.6× 20 0.2× 31 1.4k
M Błaszczyk United States 16 402 0.6× 1.0k 2.1× 678 2.1× 202 1.3× 75 0.8× 29 1.4k

Countries citing papers authored by Kurt C. Gunter

Since Specialization
Citations

This map shows the geographic impact of Kurt C. Gunter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurt C. Gunter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurt C. Gunter more than expected).

Fields of papers citing papers by Kurt C. Gunter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kurt C. Gunter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurt C. Gunter. The network helps show where Kurt C. Gunter may publish in the future.

Co-authorship network of co-authors of Kurt C. Gunter

This figure shows the co-authorship network connecting the top 25 collaborators of Kurt C. Gunter. A scholar is included among the top collaborators of Kurt C. Gunter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kurt C. Gunter. Kurt C. Gunter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Mendicino, Michael, et al.. (2019). Current state of U.S. Food and Drug Administration regulation for cellular and gene therapy products: potential cures on the horizon. Cytotherapy. 21(7). 699–724. 41 indexed citations
3.
Gunter, Kurt C., et al.. (2019). Woodscraper - highrise according to the circular economy. IOP Conference Series Earth and Environmental Science. 225. 12021–12021. 1 indexed citations
4.
Rouce, Rayne H., Birju Mehta, Sandhya Sharma, et al.. (2016). Rapidly-Generated EBV-Specific T Cells (EBVST-cells) to Treat Type 2 Latency Lymphoma. Blood. 128(22). 2990–2990.
5.
Deans, Robert, Kurt C. Gunter, Massimo Dominici, & Miguel Forte. (2015). Part 5: Unproven cell therapies and the commercialization of cell-based products. Cytotherapy. 18(1). 138–142. 7 indexed citations
6.
Godfrin, Yann, Françoise Horand, Robert S. Franco, et al.. (2011). International seminar on the red blood cells as vehicles for drugs. Expert Opinion on Biological Therapy. 12(1). 127–133. 72 indexed citations
7.
Cohen, Gary H., et al.. (1998). Evaluation of the Gemini infusion pump for the safe delivery of peripheral blood progenitor cells (stem cells). Journal of Clinical Apheresis. 13(1). 23–27. 3 indexed citations
8.
Ramasethu, Jayashree, et al.. (1997). When is iron supplementation appropriate for the Extremely Low Birth Weight infant? † 1418. Pediatric Research. 41. 239–239. 4 indexed citations
9.
Gunter, Kurt C.. (1995). Transfusion-Transmitted Cytomegalovirus: The Part-Time Pathogen. Pediatric Pathology & Laboratory Medicine. 15(3). 515–534. 6 indexed citations
10.
Gunter, Kurt C., Arifa S. Khan, & Philip D. Noguchi. (1993). The Safety of Retroviral Vectors. Human Gene Therapy. 4(5). 643–645. 30 indexed citations
11.
Wright, James R., Kurt C. Gunter, Hiroaki Mitsuya, et al.. (1990). Expression of a Zinc Finger Gene in HTLV-I- and HTLV-II-Transformed Cells. Science. 248(4955). 588–591. 55 indexed citations
12.
Gunter, Kurt C., Ronald N. Germain, Richard A. Kroczek, et al.. (1987). Thy-1-mediated T-cell activation requires co-expression of CD3/Ti complex. Nature. 326(6112). 505–507. 143 indexed citations
13.
Stingl, Georg, Kurt C. Gunter, Erwin Tschachler, et al.. (1987). Thy-1+ dendritic epidermal cells belong to the T-cell lineage.. Proceedings of the National Academy of Sciences. 84(8). 2430–2434. 93 indexed citations
14.
Saito, Takashi, Arthur Weiss, Kurt C. Gunter, Ethan M. Shevach, & R N Germain. (1987). Cell surface T3 expression requires the presence of both alpha- and beta-chains of the T cell receptor.. The Journal of Immunology. 139(2). 625–628. 52 indexed citations
15.
Gunter, Kurt C., Richard A. Kroczek, Ethan M. Shevach, & Ronald N. Germain. (1986). Functional expression of the murine Thy-1.2 gene in transfected human T cells.. The Journal of Experimental Medicine. 163(2). 285–300. 26 indexed citations
16.
Kroczek, Richard A., Kurt C. Gunter, Ronald N. Germain, & Ethan M. Shevach. (1986). Thy-1 functions as a signal transduction molecule in T lymphocytes and transfected B lymphocytes. Nature. 322(6075). 181–184. 165 indexed citations
17.
Kroczek, Richard A., Kurt C. Gunter, Bruce Seligmann, & Ethan M. Shevach. (1986). Induction of T cell activation by monoclonal anti-Thy-1 antibodies.. The Journal of Immunology. 136(12). 4379–4384. 112 indexed citations
18.
Lögdberg, Lennart, Kurt C. Gunter, & Ethan M. Shevach. (1985). Rapid production of monoclonal antibodies to T lymphocyte functional antigens. Journal of Immunological Methods. 79(2). 239–249. 18 indexed citations
19.
Gunter, Kurt C., Thomas R. Malek, & Ethan M. Shevach. (1984). T cell-activating properties of an anti-Thy-1 monoclonal antibody. Possible analogy to OKT3/Leu-4.. The Journal of Experimental Medicine. 159(3). 716–730. 271 indexed citations
20.
Rengachary, Setti S., et al.. (1982). Neurofibroma of the Infratemporal Fossa: Case Report and Technical Note. Neurosurgery. 11(1_pt_1). 43–47. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026